After leaving FDA, Cavazzoni joins Pfizer as CMO

Weeks after stepping down as director of FDA’s Center for Drug Evaluation and Research, Patrizia Cavazzoni is rejoining Pfizer Inc. (NYSE:PFE) as EVP and CMO. Cavazzoni, a former SVP and head of clinical sciences and operations at Pfizer, also had industry experience at Eli Lilly and Co. (NYSE:LLY) and Sanofi (Euronext:SAN; NASDAQ:SNY) before her 2018 arrival at FDA. She resigned from FDA in January, days before the inauguration of President Donald Trump.

Three companies announced new CFOs. Protein optimization company Nuclera Ltd. hired Seth Benson as CFO. Benson was CFO at Vizgen Inc., a spatial genomics company. Nuclera raised a $75 million series C round in October led by Elevage Medical Technologies...